• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1989 Fiscal Year Final Research Report Summary

Effects of methamphetamine on urinary levels of 2-phenylethylamine and phenylacetic acid.

Research Project

Project/Area Number 63570513
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Psychiatric science
Research InstitutionINSTITUTE OF BRAIN DISEASES, KURUME UNIVERSITY SCHOOL OF MEDICINE

Principal Investigator

YAMADA Shigeto  KURUME UNIV.SCH.MED., ASSOCIATE PROF., 医学部, 助教授 (20158190)

Co-Investigator(Kenkyū-buntansha) ISHIBASHI Masahiko  KURUME UNIV.SCH.MED., RES.FELLOW, 医学部, 助手
YOKOO Hideyasu  KURUME UNIV.SCH. MED., RES.FELLOW, 医学部, 助手 (00174847)
NISHI Syogoro  KURUME UNIV.SCH.MED., PROF., 医学部, 教授 (00080557)
Project Period (FY) 1988 – 1989
KeywordsMETHAMPHETAMINE / 2-PHENYLETHYLAMINE / PHENYLACETIC ACID / GC-MS
Research Abstract

Effects of methamphetamine (MAP) on the metabolism of 2-phenyl- ethylamine (PEA) were investigated. Levels of urinary PEA and phenylacetic acid (PAA),which is major metabolite of PEA were determined in patients suffered from MAP psychosis or in rats treated with MAP by gas chromatography-mass spectrometry or gas chromatography. In patients urine which were collected on the first day of admission, MAP excretion had a significantly positive correlation (r=0.81, P<0.01, n=22) with PAA excretion, but not with PEA excretion. The amount of PAA in patients urine were higher than that of normal volunteers but not significant. On the other hand, PEA excretion in patients urine were significantly lower than that of normal volunteers. Urinary excretion of PAA in rats housed in metabolic cages were significantly increased by the administration of HAP (2mg/kg i.p.). On the other hand, the HAP treatment caused a significant reduction in urinary PEA level. These data suggest that HAP caused the enhancement of PEA disposition and PAA production which would be metabolized from PEA.

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] 山田茂人,猪口隆洋,石橋正彦,横尾秀康,三木浩司,横山敏登,小島秀樹,西彰五郎,稲永和豊: "GC-MSによる生体試量中のMethamphetamine,2-pherylethylamineの同時定量" 日本医用マススペクトル学会講演集. 13. 161-164 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山田茂人,石橋正彦,三根芳明,猪口隆洋,横山敏登,西彰五郎,稲永和豊: "メタンフェタミン慢性中毒患者尿中のメタンフェタミンとフェニルエチラミン排泄" 薬物・精神・行動(Jpn.J.Psychopharmacol). 8. 151-152 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山田茂人,石橋正彦,西彰五郎,横尾秀康,横山敏登: "慢性覚醒剤中毒患者尿中の2ーphenylethylamineとphenylacetic acidの定量" 薬物・精神・行動(Jpn.J.Psychopharmacol.). 10. (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S.Yamada, T.Inokuchi, M.Ishibashi, H.Yokoo, K.Miki, T.Yokoyama, H.Kojima, S.Nishi, K.Inanaga: "Simultaneous determination of methamphetamine and 2-phenylethylamine in biological materials." Proceedings of the japanese society for biomedical mass spectrometry, 13, 161-164, 1988.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S.Yamada, M.Ishibashi, Y.Mine, T.Inokuchi, T.Yokoyama, S.Nishi, K.Inanaga: "Methamphetamine and phenylethylamine excretion in patients suffered from methamphetamine psychosis." Jpn.J.Psychopharmacol., 8, 151-152, 1988.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S.Yamada, M.Ishibashi, S.Nishi, H.Yokoo, T.Yokoyama: "Effect of methamphetamine on 2-phenylethylamine and phenylacetic acid excretion in human urine" Jpn.J.Psychopharmacol., 10 in press.

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1993-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi